Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3Neoplasms 2Skin Diseases 1Sarcoma 1Ovarian Neoplasms 1Neoplasms by Site 1Breast Diseases 1

Interventions

palbociclib 1ipatasertib 1exemestane 1atezolizumab 1Watchful Waiting 1Trabectedin 1Sodium Chloride 1Paclitaxel 1Low-Level Light Therapy 1Gonadotropin-Releasing Hormone 1Floderm topical cream 1Everolimus 1Docetaxel 1Capecitabine 1Botulinum Toxins, Type A 1Anastrozole 1AZD9833 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Diseases × Trabectedin × Breast × Clear all
NCT00050427 2011-04-28

A Study of ET-743 (Trabectedin) in Patients With Advanced Breast Cancer

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 2 Completed
53 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡